GlassScriptPhysician profile
David D Buckland
NPI 1700013570
$11,079.65
in general payments reported to CMS, 2019-2025
61 companies · $28.71 in 2025
The $28.71 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,003 · 2020: $1,274 · 2021: $2,273 · 2022: $3,038 · 2023: $3,118 · 2024: $346 · 2025: $28.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,492.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,420.23 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Genzyme Corporation | $555.98 | 2019-2023 | |
| Acadia Pharmaceuticals INC | $529.34 | 2019-2023 | Nuplazid |
| Novartis Pharmaceuticals Corporation | $526.46 | 2019-2023 | |
| Neurocrine Biosciences, INC. | $499.33 | 2020-2023 | Ingrezza, Ongentys |
| Sunovion Pharmaceuticals INC. | $498.36 | 2019-2022 | |
| Mdd US Operations, LLC | $483.90 | 2020-2024 | Gocovri, Gocovri |
| Biogen, INC. | $418.26 | 2019-2023 | Vumerity, Tysabri, Plegridy |
| Avanir Pharmaceuticals, INC. | $413.85 | 2019-2022 | |
| Sk Life Science, INC. | $409.83 | 2020-2023 | |
| Pfizer INC. | $398.83 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $389.87 | 2019-2023 | Austedo Xr, Austedo |
| Emd Serono, INC. | $343.89 | 2019-2023 | Mavenclad |
| Biohaven Pharmaceuticals, INC. | $330.94 | 2020-2021 | |
| Ucb, INC. | $322.11 | 2019-2023 | Fintepla, Briviact |
Show all 61 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Buckland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.